Methandienone belongs to the group of anabolic agents, used systemically.
The preparation is used for treatment of a number of diseases related to muscular dystrophy, rapid weight loss, as well as concomitant therapy in treatment of burns, after injuries, radiation, surgical intervention.
By its origin, said drug is an anabolic steroid derived from androstane. The drug integrates into the nucleus of the cell, activates its gene structure. This in turn increases the synthesis of DNA, RNA and structural proteins, activates enzymatic chains affecting tissue respiration, oxidative phosphorylation, ATP synthesis, helps to accumulate intracellular macroergues.
The active ingredient promotes anabolism processes and suppresses catabolism processes that cause glucocorticoids. The action of the drug leads to an increase in muscle mass, a decrease in adipose tissue deposition and a negative nitrogen balance. The effect of the preparation on hematopoiesis is related to the growth of synthetic activity of erythropoietin.